mutation

You have access
PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy
JUNGSUP BYUN, NORA JEE-YOUNG PARK, GHILSUK YOON, MIN KYU KANG, HYE JIN KIM, SOO YEUN PARK, JUN SEOK PARK, GYU SEOG CHOI, JIN HO BAEK, JONG GWANG KIM and AN NA SEO

Anticancer Research April 2023, 43 (4) 1513-1520; DOI: https://doi.org/10.21873/anticanres.16300
You have access
A Clinicopathological Study of Young-onset Hepatocellular Carcinoma
KWAN-YUNG AU, KRISTY KWAN-SHUEN CHAN and REGINA CHEUK-LAM LO

Anticancer Research June 2021, 41 (6) 2933-2944; DOI: https://doi.org/10.21873/anticanres.15075
You have access
Discovery of a Novel Chemical Scaffold Against Mutant Isocitrate Dehydrogenase 1 (IDH1)
CHUNG HYO KANG, SANG UN CHOI, YOU HWA SON, HEUNG KYOUNG LEE, HYE GWANG JEONG, CHANG-SOO YUN, SUNJOO AHN and CHI HOON PARK

Anticancer Research September 2020, 40 (9) 4929-4935; DOI: https://doi.org/10.21873/anticanres.14496
You have access
Separating Response of Tumor and non-Tumor Cells to Drug In Vitro by Quantifying a Mutation
MARKUS KLEINPOPPEN, CHRISTOPH MOEBIUS, KATHARINA GRUPP, LAN KLUWE and MARCO BLESSMANN

Anticancer Research April 2019, 39 (4) 1777-1783; DOI: https://doi.org/10.21873/anticanres.13284
You have access
Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133
AKHOURI A. SINHA and MICHAEL J. WILSON

Anticancer Research October 2018, 38 (10) 5725-5732; DOI: https://doi.org/10.21873/anticanres.12910
You have access
Frequency of the Loss of Heterozygosity of the NF2 Gene in Sporadic Spinal Schwannomas
RAIMUNDO MIRANDA DE CARVALHO, CARLA DE CASTRO SANT' ANNA, GIOVANNY REBOUÇAS PINTO, ERIC HOMERO ALBUQUERQUE PASCHOAL, FABRICIO MESQUITA TUJI, BARBARA DO NASCIMENTO BORGES, PAULO CARDOSO SOARES, ALBERTO GOMES FERREIRA JÚNIOR, JUAN ANTONIO REY, LUIZ CLÁUDIO LOPES CHAVES and ROMMEL RODRIGUEZ BURBANO

Anticancer Research April 2018, 38 (4) 2149-2154;
You have access
CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation
KIYONG NA, EUN KYUNG KIM, WONJUN JANG and HYUN-SOO KIM

Anticancer Research June 2017, 37 (6) 3249-3258;
You have access
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas
DEMETRIOS MORIS, CHRISTOS DAMASKOS, ELEFTHERIOS SPARTALIS, ALEXANDROS PAPALAMPROS, SPYRIDON VERNADAKIS, DIMITRIOS DIMITROULIS, JOHN GRINIATSOS, EVANGELOS FELEKOURAS and NIKOLAOS NIKITEAS

Anticancer Research May 2017, 37 (5) 2185-2194;
You have access
Prognostic Impact of EGFR Driver Mutations on Postoperative Disease Recurrence in Lung Adenocarcinoma
TATSURO OKAMOTO, HIROKAZU KITAHARA, SHINICHIRO SHIMAMATSU, MASAKAZU KATSURA, KAZUKI TAKADA, TAKATOSHI FUJISHITA, YUZO SUZUKI, YOSUKE MORODOMI, TETSUZO TAGAWA and YOSHIHIKO MAEHARA

Anticancer Research June 2016, 36 (6) 3057-3063;
You have access
Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome
MARTIN SANDELIN, ANDERS BERGLUND, MAGNUS SUNDSTRÖM, PATRICK MICKE, SIMON EKMAN, MICHAEL BERGQVIST, STEFAN BERGSTRÖM, HIRSH KOYI, EVA BRANDÉN, CHRISTER JANSON and JOHAN BOTLING

Anticancer Research July 2015, 35 (7) 3979-3985;

Main menu

User menu

Search

mutation

Pages